BVT.13 is an orally active and selective PPARgamma agonist with maximal efficacy comparable to rosiglitazone, BVT.13 demonstrates antidiabetic activity in ob/ob mice, showing potential in metabolism research.
Molecular Weight:
404.2
Purity:
98.59%
CAS Number:
[756813-87-3]
Formula:
C18H11Cl2N3O4
Target:
PPAR
T25193
T25193
* VAT and and shipping costs not included. Errors and price changes excepted